Evaluation of a Non-invasive Urinary Collection Technique for the Adaptation of Diuretic Treatment in Incontinent Heart Failure Patient Over 75 Years of Age in the Acute Phase

NCT ID: NCT05186428

Last Updated: 2023-11-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-06

Study Completion Date

2024-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Heart failure is a general disease affecting many organs and regulatory systems with a prevalence of 10% after 75 years of age, leading to significant hospitalization in the elderly. This generates a significant cost for our health system. The management of patients over 75 years of age in acute heart failure requires special monitoring of diuresis and weight. However, it is sometimes difficult to collect urine from incontinent elderly patients (not catheterized, habitually wearing protection) under intravenous diuretics. The evaluation of a non-invasive technique of urine collection for the adaptation of diuretic treatment in the incontinent patient with heart failure over 75 years of age in the acute phase seems to us to be interesting to conduct.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diuresis in Incontinent Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

The "before" period

Group Type OTHER

carrying out standard care

Intervention Type OTHER

The adaptation of the diuretic treatment will be made according to the possible diuresis records and the weighing of the patient every 2 days.

the "after" period

Group Type EXPERIMENTAL

adult diaper

Intervention Type OTHER

the diuresis which will be calculated by making the difference between the weight of the soiled protection weighed and the weight of the dry protection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

carrying out standard care

The adaptation of the diuretic treatment will be made according to the possible diuresis records and the weighing of the patient every 2 days.

Intervention Type OTHER

adult diaper

the diuresis which will be calculated by making the difference between the weight of the soiled protection weighed and the weight of the dry protection

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient over 75 years of age
* Geriatric short-stay inpatient, geriatric/cardio medicine unit geriatrics
* Incontinent patient with urinary protection
* Patient with acute heart failure according to the diagnosis made by the doctors of unity
* Patient treated with intravenous diuretic
* Patient benefiting from a social security scheme or benefiting from it by a third party
* Patient who gave their non-opposition to the study after clear information

Exclusion Criteria

* Patient hospitalized in another unit of the geriatric division
* Patient allergic to the protections provided
* Patient carrying a bladder probe upon entry into the unit
* Patient with a precarious non-perfusable venous capital
Minimum Eligible Age

75 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Poitiers University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sophie PAJOUX

Role: PRINCIPAL_INVESTIGATOR

CHU de Poitiers FRANCE

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Poitiers

Poitiers, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sophie PAJOUX

Role: CONTACT

Fanny ABRIAT

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sophie PAJOUX

Role: primary

Fanny ABRIAT

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ATIICA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.